Toronto Dominion Bank purchased a new position in HCM II Acquisition Corp. (NASDAQ:HOND - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 31,687 shares of the company's stock, valued at approximately $318,000. Toronto Dominion Bank owned 0.11% of HCM II Acquisition as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Picton Mahoney Asset Management bought a new stake in shares of HCM II Acquisition during the 4th quarter valued at $19,840,000. AQR Arbitrage LLC bought a new stake in HCM II Acquisition during the fourth quarter valued at about $15,670,000. LMR Partners LLP bought a new stake in HCM II Acquisition during the fourth quarter valued at about $15,030,000. D. E. Shaw & Co. Inc. purchased a new position in shares of HCM II Acquisition in the fourth quarter valued at about $9,218,000. Finally, Wolverine Asset Management LLC bought a new position in shares of HCM II Acquisition in the fourth quarter worth about $7,675,000.
HCM II Acquisition Stock Up 0.4%
HOND stock traded up $0.05 during mid-day trading on Tuesday, hitting $11.83. The company had a trading volume of 1,329,478 shares, compared to its average volume of 219,577. HCM II Acquisition Corp. has a 12-month low of $9.90 and a 12-month high of $12.24. The firm's 50-day moving average price is $10.91.
HCM II Acquisition Company Profile
(
Free Report)
HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.
See Also
Before you consider HCM II Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCM II Acquisition wasn't on the list.
While HCM II Acquisition currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
